Afsaneh Barzi - Publications, H-index & Citations

Afsaneh Barzi

pennsylvania medicine

29H指数

339论文数

6.6K被引数

收录论文 71

发表时间

Efficacy and Descriptive Safety Assessment of Programmed Cell Death Protein-(Ligand) 1 Inhibitors Plus Chemotherapy as First-Line Treatment for Gastric and Gastroesophageal Junction Cancer in Asian and Non-Asian Patients: A Meta-Analysis 亚洲和非亚洲患者中程序性细胞死亡蛋白-(配体)1抑制剂联合化疗作为胃癌和胃食管结合部癌一线治疗的疗效和安全性描述性评估：一项Meta分析

Gastro Hep Advances

IF0

2026-01-01

OAAI

Lordick, Florian; Dotan, Efrat; Zhan, Lin; Zhang, Xiaowei; Barzi, Afsaneh; Ghali, Nadeem; Lee, Keun-Wook; Klempner, Samuel J.; Strickland, Matthew R.; Lonardi, Sara; Satoh, Taroh

Cost-effectiveness analysis of regorafenib dose optimization for refractory metastatic colorectal cancer regorafenib剂量优化在难治性转移性结直肠癌中的成本效益分析

JOURNAL OF MEDICAL ECONOMICS

IF3

2025-04-28

OAAI

Bekaii-Saab, Tanios; Cho, Sang Kyu; Hocum, Brian; Grossman, Jamie; Appukkuttan, Sreevalsa; Babajanyan, Svetlana; Marian, Marisca; Lee, Woojung; Barzi, Afsaneh; Yang, Min

Patient-Physician Communication Experience Modifies Racial/Ethnic Health Care Disparities Among Surveillance, Epidemiology, and End Results-Consumer Assessment of Healthcare Providers and Systems Participants With Colorectal Cancer and Multiple Chronic Conditions

MEDICAL CARE

IF2.8

2024-12-27

PREAI

Navarro, Stephanie; Le, Jessica; Tsui, Jennifer; Barzi, Afsaneh; Stern, Mariana C.; Pickering, Trevor; Farias, Albert J.

Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases 胆道癌腹膜转移患者腹腔内加压雾化化疗的安全性

FUTURE ONCOLOGY

IF2.6

2024-09-12

PREAI

Li, Daneng; Crook, Christiana; Chung, Vincent; Brar, Gagandeep; Fakih, Marwan; Barzi, Afsaneh; Melstrom, Laleh; Singh, Gagandeep; Fong, Yuman; Frankel, Paul; Raoof, Mustafa

Use of FOLFOXIRI Plus Bevacizumab and Subsequent Therapies in Metastatic Colorectal Cancer: An Age-Stratified Analysis

CLINICAL COLORECTAL CANCER

IF3.2

2024-09-01

PREAI

Vassilev, Zdravko P.; Fan, Xiaozhou; Xu, Julie; Ostojic, Helene; Barzi, Afsaneh

Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans

JAMA HEALTH FORUM

IF11.3

2024-05-31

OAAI

Li, Yonghong; Heer, Avneet K.; Sloane, Hillary S.; Edelstein, Daniel L.; Tie, Jeanne; Gibbs, Peter; Barzi, Afsaneh

ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition

FRONTIERS IN ONCOLOGY

IF3.3

2024-02-08

OAAI

Barzi, Afsaneh; Weipert, Caroline M.; Espenschied, Carin R.; Raymond, Victoria M.; Wang-Gillam, Andrea; Nezami, Mohammad Amin; Gordon, Eva J.; Mahadevan, Daruka; Mody, Kabir

Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study

CLINICAL CANCER RESEARCH

IF10.2

2024-01-16

OAAI

Ahn, Daniel H.; Barzi, Afsaneh; Ridinger, Maya; Samuelsz, Errin; Subramanian, Ramanand A.; Croucher, Peter J. P.; Smeal, Tod; Kabbinavar, Fairooz F.; Lenz, Heinz-Josef

Associations Between Patient Experience With Care, Race and Ethnicity, and Receipt of CRC Treatment Among SEER-CAHPS Patients With Multiple Comorbidities

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-01-01

OAAI

Navarro, Stephanie; Tsui, Jennifer; Barzi, Afsaneh; Stern, Mariana C.; Pickering, Trevor; Farias, Albert J.

Racial and ethnic disparities in self-reported general and mental health status among colorectal cancer survivors: impact of sociodemographic factors and implications for mortality-a SEER-CAHPS study

QUALITY OF LIFE RESEARCH

IF2.7

2023-12-28

OAAI

Yoon, Paul S.; Navarro, Stephanie; Barzi, Afsaneh; Ochoa-Dominguez, Carol Y.; Arizpe, Angel; Farias, Albert J.

Pancreatic Adenocarcinoma: Real World Evidence of Care Delivery in AccessHope Data

JOURNAL OF PERSONALIZED MEDICINE

IF3

2023-09-15

OAAI

Barzi, Afsaneh; Kim, Angela J.; Liang, Crystal K.; West, Howard; Wong, D.; Wright, Carol; Nathwani, Nitya; Vasko, Catherine M.; Chung, Vincent; Rubinson, Douglas A.; Sachs, Todd

Patient race and ethnicity, experiences with care, and guideline concordant treatment for colorectal cancer among those with multimorbidity

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Navarro, Stephanie; Tsui, Jennifer; Barzi, Afsaneh; Stern, Mariana; Pickering, Trevor; Farias, Albert

Patient Care Satisfaction and Emergency Room Utilization among Young Adult Colorectal Cancer Survivors during the SARS-CoV-2 Pandemic: Lessons Learned

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-01-06

OAAI

Kagramanov, Dalia; Miller, Kimberly A. A.; Gallagher, Phuong; Freyer, David R. R.; Milam, Joel E. E.; Lenz, Heinz-Josef; Barzi, Afsaneh

Multimorbidity and the association with patient reported access to care and physician relationships among racially and ethnically diverse patients with colorectal cancer

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2023-01-01

PREAI

Navarro, Stephanie; Stern, Mariana C.; Barzi, Afsaneh; Farias, Albert J.

Value-Based Analysis of Therapies in Refractory Metastatic Colorectal Cancer in US 美国难治性转移性结直肠癌治疗的价值分析

CLINICAL COLORECTAL CANCER

IF3.2

2022-12-01

OAAI

Cho, Sang Kyu; Bekaii-Saab, Tanios; Kavati, Abhishek; Babajanyan, Svetlana; Hocum, Brian; Barzi, Afsaneh

Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-11-14

OAAI

Bosserman, Linda D.; Mambetsariev, Isa; Ladbury, Colton; Barzi, Afsaneh; Johnson, Deron; Morse, Denise; Deaville, Debbie; Smith, Wade; Rajurkar, Swapnil; Merla, Amartej; Hajjar, George; Kim, Daniel; Fricke, Jeremy; Trisal, Vijay; Salgia, Ravi

MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma: Trial in progress MOUNTAINEER-02: tucatinib，曲妥珠单抗，ramucirumab和紫杉醇在先前治疗过的HER2胃或胃食管交界处腺癌中的2/3期研究: 正在进行的试验

ANNALS OF ONCOLOGY

IF65.4

2022-06-01

OAAI

Tabernero, J.; Strickler, J.; Nakamura, Y.; Shitara, K.; Janjigian, Y.; Barzi, A.; Bekaii-Saab, T.; Lenz, H.; Yoshino, T.; Siena, S.; Garrido-Mayor, J.; Ubowski, M.; Xie, D.; Marshall, J.

MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress

ANNALS OF ONCOLOGY

IF65.4

2021-09-01

OAAI

Catenacci, D. V.; Strickler, J. H.; Shitara, K.; Nakamura, Y.; Janjigian, Y. Y.; Barzi, A.; Bekaii-Saab, T.; Lenz, H. J.; Chung, H. C.; Tabernero, J.; Yoshino, T.; Siena, S.; Mayor, J. G.; Palanca-Wessels, M. C.; Xie, D.; Marshall, J. L.

Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study 了解胆道癌的患者体验: 一项定性的患者访谈研究

ONCOLOGY AND THERAPY

IF3.2

2021-07-10

OAAI

Patel, Nikunj; Lie, Xandra; Gwaltney, Chad; Rokutanda, Nana; Barzi, Afsaneh; Melisi, Davide; Macarulla, Teresa; Ueno, Makoto; Kim, Seung Tae; Meyers, Oren; Workman, Christina; Bachini, Melinda; Cohen, Gordon

MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma: Trial in progress

ANNALS OF ONCOLOGY

IF65.4

2021-07-01

OAAI

Strickler, J.; Nakamura, Y.; Shitara, K.; Catenacci, D.; Janjigian, Y.; Barzi, A.; Bekaii-Saab, T.; Lenz, H.; Lee, J.; Van Cutsem, E.; Chung, H.; Tabernero, J.; Yoshino, T.; Siena, S.; Garrido-Mayor, J.; Palanca-Wessels, M.; Xie, D.; Marshall, J.

研究方向